Editorial: Rapidly Growing Importance of Glycated Haemoglobin (HbA1c) in Diabetic Management


 Glycated Haemoglobin (HbA1c), diabetes, glucose management, point-of-care devices.

How to Cite

Sandeep Kumar Vashist, & Khalid Al-Rubeaan. (2013). Editorial: Rapidly Growing Importance of Glycated Haemoglobin (HbA1c) in Diabetic Management. Journal of Basic & Applied Sciences, 9, 337–340. https://doi.org/10.6000/1927-5129.2013.09.43


Glycated Haemoglobin (HbA1c) has become an integral part of glucose management in diabetes mellitus patients as it corresponds to their average blood glucose level in past few weeks. The improved glucose management is clearly apparent to the healthcare professionals from the reduced and sustained HbA1c level in diabetics. HbA1c has also been recently advocated as a diagnostic marker for diabetes mellitus. During the past two decades, tremendous improvements have been made in the development of laboratory-based reference methods for HbA1c analysis and the development of secondary HbA1c reference material that is being used worldwide for the standardisation of HbA1c methods. The current generation of point-of-care (POC) instruments for HbA1c analysis lacks the generally-accepted analytical performance criteria, thereby stressing the need for critical improvement in POC devices and HbA1c methods.



Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pr 2010; 87: 293-301. http://dx.doi.org/10.1016/j.diabres.2010.01.026

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53. http://dx.doi.org/10.2337/diacare.27.5.1047

IDF Diabetes Atlas, 5th edition, 2012 update. http://www.idf.org/sites/default/files/5E_IDFAtlasPoster_2012_EN.pdf [Accessed on April 24, 2013

Lenters-Westra E, Schindhelm RK, Bilo HJ, Slingerland RJ. Haemoglobin A1c: Historical overview and current concepts. Diabetes Res Clin Pr 2013; 99: 75-84. http://dx.doi.org/10.1016/j.diabres.2012.10.007

Higgins T. HbA1c – An analyte of increasing importance. Clin Biochem 2012; 45: 1038-45. http://dx.doi.org/10.1016/j.clinbiochem.2012.06.006

Gillett MJ. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes: Diabetes Care 2009; 32(7): 1327-34. Clin Biochem Rev 2009; 30: 197-200.

Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus http://www.who.int/diabetes/publications/ report-hba1c_2011.pdf [Accessed on April 24, 2013

Rahbar S. An abnormal haemoglobin in red cells of diabetics. Clin Chim Acta 1968; 22: 296-8. http://dx.doi.org/10.1016/0009-8981(68)90372-0

Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual haemoglobin in patients with diabetic mellitus. Biochem Biophys Res Commun 1969; 36: 838-45. http://dx.doi.org/10.1016/0006-291X(69)90685-8

Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. N Eng J Med 1971; 284: 353-7. http://dx.doi.org/10.1056/NEJM197102182840703

National Glycohemoglobin Standardization Program. Background. http://www.ngsp.org/bground.asp [Accessed on April 24, 2013

Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002; 40: 78-89. http://dx.doi.org/10.1515/CCLM.2002.016

Finke A, Kobold U, Hoelzel W, Weycamp C, Jeppsson JO, Miedema K. Preparation of a candidate primary reference material for the international standardisation of HbA1c determinations. Clin Chem Lab Med 1998; 36: 299-308. http://dx.doi.org/10.1515/CCLM.1998.051

Geistanger A, Arends S, Berding C, Hoshino T, Jeppsson JO, Little R, et al. On behalf of the IFCC Working Group on Standardization of HbA1c: Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan and Sweden. Clin Chem 2008; 54: 1379-85. http://dx.doi.org/10.1373/clinchem.2008.103556

Sacks DB. ADA/EASD/IDF Working Group of the HbA1c Assay. Global harmonization of hemoglobin A1c. Clin. Chem 2005; 51: 681-3. http://dx.doi.org/10.1373/clinchem.2004.047431

Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, et al. Translating the A1c assay into estimated average glucose values. Diabetes Care 2008; 31: 1-6. http://dx.doi.org/10.2337/dc08-0545

Waikato District Health Board (2012). Laboratory test reference guide. http://www.waikatodhb.govt.nz/lab/ [Accessed on Apr 24, 2013

Vashist SK, Zheng D, Al-Rubeaan K, Luong JH, Sheu, FS. Technology behind commercial devices for blood glucose monitoring in diabetes management: A review. Anal Chim Acta 2011; 703: 124-36. http://dx.doi.org/10.1016/j.aca.2011.07.024

Little RR, Lenters-Westra E, Rohlfing CL, Slingerland R. Point-of-Care Assays for Hemoglobin A1c: Is Performance Adequate? Clin Chem 2011; 57: 1333-4. http://dx.doi.org/10.1373/clinchem.2011.165019

Leca V, Ibrahim Z, Lombard-Pontou E, Maraninchi M, Guieu R, Portugal H, et al. Point-of-Care Measurements of HbA1c: Simplicity Does Not Mean Laxity With Controls. Diabetes Care 2012; 35: e85. http://dx.doi.org/10.2337/dc12-0751

Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem 2010; 56: 44-52. http://dx.doi.org/10.1373/clinchem.2009.130641

Timar B, Albai O. The relationship between hemoglobin A1c and chronic complications in diabetes mellitus: Rom J Diabetes Nutr Metab Dis 2012; 19: 115-22.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2013 Sandeep Kumar Vashist , Khalid Al-Rubeaan